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The discovery of microRNAs is one of the major scienti-
fic breakthroughs in recent years and has revolutionized
the way we look at gene regulation. MicroRNAs are
small non-coding RNAs that regulate the expression of
protein-coding genes via posttranscriptional suppression.
Each microRNA can regulate dozens to hundreds of
genes, making their regulatory potential enormous.
MicroRNAs regulate basic biological processes and have
been implicated in the development of the immune sys-
tem as well as in immune responses.
In line with their essential role in physiological pro-
cesses, deregulation of microRNAs has been linked to
human diseases. MicroRNAs are frequently deregulated
in cancers. In the past few years, dozens of microRNAs
were identified, which act as tumor suppressors or onco-
gens and regulate carcinogenesis, tumor progression and
metastasis. Recently, deregulation of microRNAs has
been shown in chronic inflammatory and immune-
mediated diseases such as psoriasis, atopic dermatitis,
rheumatoid arthritis and systemic lupus erythematosus.
However, we are still at the beginning in understanding
their roles in the regulation of inflammatory pathways
and the pathogenesis of inflammatory diseases.
Since microRNA levels can be modulated by introdu-
cing microRNA mimics and inhibitors to the cells, we
predict that overexpression or suppression of microRNA
levels may become a novel therapeutic approach in the
treatment of cancer and inflammatory diseases in the
future.
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